How can smart policy secure America’s leadership in biotechnology? BIO President & CEO John F. Crowley outlined the path forward in Senate testimony and a joint op-ed with Sen. Todd Young (R-IN). (703 ...

Lack of vaccination is allowing a measles comeback. Also, a sickle cell advocate explains why speaking out matters. (637 words, 3 minutes, 11 seconds) Measles: Completely preventable but making a ...

A Senate hearing promotes legislation that would provide clarity on patents. Also: heroism and advocacy around arthritis. (670 words, 3 minutes, 21 seconds) Senators push fix for patent clarity to ...

BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

Mark leads the Biotechnology team at Carpmaels & Ransford. Mark’s impressive Biotech-only practice focusses on the rapid and effective building of commercially valuable European patent portfolios for ...

Gautam Prakash is the Associate Vice President for Intellectual Property Policy and Advocacy at Eli Lilly and Company. In this role he advocates for a robust IP system that protects biopharmaceutical ...

Emily Michiko Morris, an experienced teacher and scholar in specializing in patent law, particularly as it relates to biotechnology and university research, and is an expert on intellectual property ...